Načítá se...
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
• Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor.
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3862295/ https://ncbi.nlm.nih.gov/pubmed/24371708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gynor.2013.07.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|